HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Oculopharyngeal Muscular Dystrophy

An autosomal dominant hereditary disease that presents in late in life and is characterized by DYSPHAGIA and progressive ptosis of the eyelids. Mutations in the gene for POLY(A)-BINDING PROTEIN II have been associated with oculopharyngeal muscular dystrophy.
Also Known As:
Muscular Dystrophy, Oculopharyngeal; Dystrophies, Oculopharyngeal Muscular; Dystrophy, Oculopharyngeal Muscular; Muscular Dystrophies, Oculopharyngeal; Oculopharyngeal Muscular Dystrophies
Networked: 141 relevant articles (1 outcomes, 7 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Facial Pain (Myofacial Pain)
2. Inclusion Body Myositis
3. Muscular Diseases (Myopathy)
4. Muscular Dystrophies (Muscular Dystrophy)
5. Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)

Experts

1. Brais, Bernard: 12 articles (06/2010 - 08/2003)
2. Rouleau, Guy A: 11 articles (06/2010 - 08/2003)
3. Rubinsztein, David C: 9 articles (03/2011 - 04/2002)
4. van der Maarel, Silvère M: 8 articles (04/2014 - 01/2006)
5. Trollet, Capucine: 7 articles (03/2015 - 01/2011)
6. Raz, Vered: 7 articles (04/2014 - 01/2011)
7. Davies, Janet E: 7 articles (03/2011 - 06/2005)
8. Schwarz, Elisabeth: 6 articles (11/2015 - 02/2008)
9. Brais, B: 6 articles (01/2013 - 08/2000)
10. Dickson, George: 5 articles (05/2015 - 01/2011)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Oculopharyngeal Muscular Dystrophy:
1. Poly(A)-Binding Protein IIIBA
2. Poly(A)-Binding Proteins (Poly(A)-Binding Protein)IBA
3. UbiquitinIBA
4. Creatine Kinase (Creatine Phosphokinase)IBA
5. Lactic AcidFDA LinkGeneric
6. Amyloid beta-PeptidesIBA
7. CollagenIBA
8. desmuslin (synemin)IBA
9. tranilast (N 5')IBA
10. polyalanineIBA

Therapies and Procedures

1. Rhytidoplasty (Facelift)
2. Transplantation (Transplant Recipients)
3. Denervation
4. Airway Management
5. Fundoplication